• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发现并评价对映纯 9-嘧啶并[4,5-]吲哚作为纳摩尔级 GSK-3β 抑制剂,具有改善的代谢稳定性。

Discovery and Evaluation of Enantiopure 9-pyrimido[4,5-]indoles as Nanomolar GSK-3β Inhibitors with Improved Metabolic Stability.

机构信息

Institute of Pharmaceutical Sciences, Department of Medicinal and Pharmaceutical Chemistry, Eberhard Karls University Tübingen, Auf der Morgenstelle 8, 72076 Tübingen, Germany.

School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, Finland.

出版信息

Int J Mol Sci. 2020 Oct 22;21(21):7823. doi: 10.3390/ijms21217823.

DOI:10.3390/ijms21217823
PMID:33105671
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7659979/
Abstract

Glycogen synthase kinase-3β (GSK-3β) is a potential target in the field of Alzheimer's disease drug discovery. We recently reported a new class of 9-pyrimido[4,5-]indole-based GSK-3β inhibitors, of which 3-(3-((7-chloro-9-pyrimido[4,5-]indol-4-yl)(methyl)amino)piperidin-1-yl)propanenitrile () demonstrated promising inhibitory potency. However, this compound underwent rapid degradation by human liver microsomes. Starting from , we prepared a series of amide-based derivatives and studied their structure-activity relationships against GSK-3β supported by 1 µs molecular dynamics simulations. The biological potency of this series was substantially enhanced by identifying the eutomer configuration at the stereocenter. Moreover, the introduction of an amide bond proved to be an effective strategy to eliminate the metabolic hotspot. The most potent compounds, ()-3-(3-((7-chloro-9-pyrimido[4,5-]indol-4-yl)(methyl)amino)piperidin-1-yl)-3-oxopropanenitrile () and ()-1-(3-((7-bromo-9pyrimido[4,5-]indol-4-yl)(methyl)amino)piperidin-1-yl)propan-1-one (), exhibited IC values of 480 nM and 360 nM, respectively, and displayed improved metabolic stability. Their favorable biological profile is complemented by minimal cytotoxicity and neuroprotective properties.

摘要

糖原合酶激酶-3β(GSK-3β)是阿尔茨海默病药物发现领域的一个潜在靶点。我们最近报道了一类新的 9-嘧啶并[4,5-e]吲哚为基础的 GSK-3β抑制剂,其中 3-(3-((7-氯-9-嘧啶并[4,5-e]吲哚-4-基)(甲基)氨基)哌啶-1-基)丙腈()表现出有希望的抑制活性。然而,该化合物在人肝微粒体中迅速降解。从开始,我们制备了一系列酰胺类衍生物,并通过 1 µs 分子动力学模拟研究了它们对 GSK-3β的构效关系。通过确定手性中心的优势构象,该系列化合物的生物活性得到了显著提高。此外,酰胺键的引入被证明是消除代谢热点的有效策略。最有效的化合物()-3-(3-((7-氯-9-嘧啶并[4,5-e]吲哚-4-基)(甲基)氨基)哌啶-1-基)-3-氧代丙腈()和()-1-(3-((7-溴-9-嘧啶并[4,5-e]吲哚-4-基)(甲基)氨基)哌啶-1-基)-1-丙酮(),其 IC 值分别为 480 nM 和 360 nM,且显示出改善的代谢稳定性。它们具有最小的细胞毒性和神经保护特性,这进一步补充了它们良好的生物学特性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd3/7659979/0c7ef7675b32/ijms-21-07823-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd3/7659979/af4f888063c4/ijms-21-07823-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd3/7659979/eb605cbdbb3d/ijms-21-07823-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd3/7659979/f281a32bcb0c/ijms-21-07823-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd3/7659979/c8bb7a8b9347/ijms-21-07823-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd3/7659979/9547ef9303dd/ijms-21-07823-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd3/7659979/0c7ef7675b32/ijms-21-07823-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd3/7659979/af4f888063c4/ijms-21-07823-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd3/7659979/eb605cbdbb3d/ijms-21-07823-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd3/7659979/f281a32bcb0c/ijms-21-07823-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd3/7659979/c8bb7a8b9347/ijms-21-07823-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd3/7659979/9547ef9303dd/ijms-21-07823-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd3/7659979/0c7ef7675b32/ijms-21-07823-sch003.jpg

相似文献

1
Discovery and Evaluation of Enantiopure 9-pyrimido[4,5-]indoles as Nanomolar GSK-3β Inhibitors with Improved Metabolic Stability.发现并评价对映纯 9-嘧啶并[4,5-]吲哚作为纳摩尔级 GSK-3β 抑制剂,具有改善的代谢稳定性。
Int J Mol Sci. 2020 Oct 22;21(21):7823. doi: 10.3390/ijms21217823.
2
Design, Synthesis and Biological Evaluation of 7-Chloro-9-pyrimido[4,5-]indole-based Glycogen Synthase Kinase-3β Inhibitors.7-氯-9-嘧啶并[4,5-]吲哚基糖原合酶激酶-3β抑制剂的设计、合成与生物评价。
Molecules. 2019 Jun 25;24(12):2331. doi: 10.3390/molecules24122331.
3
The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.新型强效 GSK-3β 抑制剂 AF3581 的稳定情绪作用。
Biomed Pharmacother. 2020 Aug;128:110249. doi: 10.1016/j.biopha.2020.110249. Epub 2020 May 26.
4
Addressing a Trapped High-Energy Water: Design and Synthesis of Highly Potent Pyrimidoindole-Based Glycogen Synthase Kinase-3β Inhibitors.解决被困高能水的问题:基于嘧啶并吲哚的高效糖原合酶激酶-3β抑制剂的设计与合成
J Med Chem. 2022 Jan 27;65(2):1283-1301. doi: 10.1021/acs.jmedchem.0c02146. Epub 2021 Jul 2.
5
Structure-Based design of Marine-derived Meridianin C derivatives as glycogen synthase kinase 3β inhibitors with improved oral bioavailability: From aminopyrimidyl-indoles to the sulfonyl analogues.基于结构的海洋衍生 Meridianin C 衍生物的设计作为糖原合酶激酶 3β抑制剂,改善口服生物利用度:从氨基嘧啶吲哚到磺酰类似物。
Bioorg Chem. 2022 Feb;119:105537. doi: 10.1016/j.bioorg.2021.105537. Epub 2021 Dec 6.
6
Discovery of new GSK-3β inhibitors through structure-based virtual screening.通过基于结构的虚拟筛选发现新型糖原合成酶激酶-3β抑制剂
Bioorg Med Chem Lett. 2018 Jan 15;28(2):160-166. doi: 10.1016/j.bmcl.2017.11.036. Epub 2017 Nov 24.
7
Design, synthesis and biological evaluation of harmine derivatives as potent GSK-3β/DYRK1A dual inhibitors for the treatment of Alzheimer's disease.设计、合成并评价哈尔满衍生物作为潜在的 GSK-3β/DYRK1A 双重抑制剂用于治疗阿尔茨海默病。
Eur J Med Chem. 2021 Oct 15;222:113554. doi: 10.1016/j.ejmech.2021.113554. Epub 2021 May 29.
8
Design and synthesis of (aza)indolyl maleimide-based covalent inhibitors of glycogen synthase kinase 3β.基于(氮杂)吲哚基马来酰亚胺的糖原合酶激酶 3β共价抑制剂的设计与合成。
Org Biomol Chem. 2018 Jun 6;16(22):4127-4140. doi: 10.1039/c8ob00642c.
9
Discovery of novel 2-(4-aryl-2-methylpiperazin-1-yl)-pyrimidin-4-ones as glycogen synthase kinase-3β inhibitors.新型2-(4-芳基-2-甲基哌嗪-1-基)嘧啶-4-酮作为糖原合酶激酶-3β抑制剂的发现
Bioorg Med Chem Lett. 2017 Aug 15;27(16):3733-3738. doi: 10.1016/j.bmcl.2017.06.077. Epub 2017 Jul 5.
10
Amaryllidaceae Alkaloids as Potential Glycogen Synthase Kinase-3β Inhibitors.石蒜科生物碱作为潜在的糖原合成酶激酶-3β抑制剂。
Molecules. 2018 Mar 21;23(4):719. doi: 10.3390/molecules23040719.

引用本文的文献

1
1-{3-[(7-Fluoro-9-pyrimido[4,5-]indol-4-yl)(meth-yl)amino]-piperidin-1-yl}propan-1-one.1-{3-[(7-氟-9-嘧啶并[4,5-]吲哚-4-基)(甲基)氨基]-哌啶-1-基}丙-1-酮
IUCrdata. 2021 Feb 23;6(Pt 2):x210159. doi: 10.1107/S2414314621001590. eCollection 2021 Feb.

本文引用的文献

1
Novel Curcumin-Diethyl Fumarate Hybrid as a Dualistic GSK-3β Inhibitor/Nrf2 Inducer for the Treatment of Parkinson's Disease.新型姜黄素-富马酸二乙酯杂合体作为一种双重 GSK-3β 抑制剂/Nrf2 诱导剂用于治疗帕金森病。
ACS Chem Neurosci. 2020 Sep 2;11(17):2728-2740. doi: 10.1021/acschemneuro.0c00363. Epub 2020 Aug 3.
2
Esculetin as a Bifunctional Antioxidant Prevents and Counteracts the Oxidative Stress and Neuronal Death Induced by Amyloid Protein in SH-SY5Y Cells.七叶亭作为一种双功能抗氧化剂可预防和对抗淀粉样蛋白在SH-SY5Y细胞中诱导的氧化应激和神经元死亡。
Antioxidants (Basel). 2020 Jun 25;9(6):551. doi: 10.3390/antiox9060551.
3
Glycogen synthase kinase-3 signaling in Alzheimer's disease.
阿尔茨海默病中的糖原合成激酶-3 信号通路。
Biochim Biophys Acta Mol Cell Res. 2020 May;1867(5):118664. doi: 10.1016/j.bbamcr.2020.118664. Epub 2020 Jan 30.
4
Pyridinylimidazoles as GSK3β Inhibitors: The Impact of Tautomerism on Compound Activity via Water Networks.作为糖原合成酶激酶3β抑制剂的吡啶基咪唑:互变异构通过水网络对化合物活性的影响。
ACS Med Chem Lett. 2019 Aug 26;10(10):1407-1414. doi: 10.1021/acsmedchemlett.9b00177. eCollection 2019 Oct 10.
5
Design, Synthesis and Biological Evaluation of 7-Chloro-9-pyrimido[4,5-]indole-based Glycogen Synthase Kinase-3β Inhibitors.7-氯-9-嘧啶并[4,5-]吲哚基糖原合酶激酶-3β抑制剂的设计、合成与生物评价。
Molecules. 2019 Jun 25;24(12):2331. doi: 10.3390/molecules24122331.
6
Pyridinylimidazoles as dual glycogen synthase kinase 3β/p38α mitogen-activated protein kinase inhibitors.嘧啶并咪唑类化合物作为双重糖原合酶激酶 3β/p38α 丝裂原活化蛋白激酶抑制剂。
Eur J Med Chem. 2019 Aug 1;175:309-329. doi: 10.1016/j.ejmech.2019.04.035. Epub 2019 Apr 24.
7
OPLS3e: Extending Force Field Coverage for Drug-Like Small Molecules.OPLS3e:扩展适用于类药物小分子的力场覆盖范围。
J Chem Theory Comput. 2019 Mar 12;15(3):1863-1874. doi: 10.1021/acs.jctc.8b01026. Epub 2019 Mar 4.
8
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design.氟原子及含氟基序在药物设计中生物等排体的设计与应用。
J Med Chem. 2018 Jul 26;61(14):5822-5880. doi: 10.1021/acs.jmedchem.7b01788. Epub 2018 Feb 5.
9
Design, synthesis, and biological evaluation of 2,4-dihydropyrano[2,3-c]pyrazole derivatives as autotaxin inhibitors.设计、合成及生物评价 2,4-二氢吡喃并[2,3-c]吡唑衍生物作为自分泌运动因子抑制剂。
Eur J Pharm Sci. 2017 Sep 30;107:97-111. doi: 10.1016/j.ejps.2017.07.002. Epub 2017 Jul 5.
10
Oxetanes: Recent Advances in Synthesis, Reactivity, and Medicinal Chemistry.环氧化合物:合成、反应性和药物化学的最新进展。
Chem Rev. 2016 Oct 12;116(19):12150-12233. doi: 10.1021/acs.chemrev.6b00274. Epub 2016 Sep 15.